LEVEL OF ANTI-MULLER HORMONE IN THE BLOOD OF WOMEN WITH INFERTILITY AT OVARIAN ENDOMETRIOSIS

A. Andriiets, О. M. Yuzko
In: Clinical & experimental pathology · 2019 · vol. 17(4) · doi:10.24061/1727-4338.xvii.4.66.2018.4 · W2936248331
article OA: diamond CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-28 ⓘ

This study found no significant difference in anti-Mullerian hormone (AMH) levels between women with infertility and endometriosis versus those with infertility alone, though AMH varied by endometriosis type and infertility history within the endometriosis group.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text ⓘ

The study evaluated serum anti-Müllerian hormone (AMH) levels in 55 infertile women with ovarian endometriosis (main group) versus 30 infertile women without ovarian endometriosis (control group) using an immunofluorescence assay. Mean AMH levels did not differ significantly between groups (3.5 ng/mL in the endometriosis group vs 3.3 ng/mL in controls). Within the endometriosis group, AMH was 3.67 ng/mL in primary infertility and 2.6 ng/mL in secondary infertility. The paper’s conclusions state that AMH levels in infertile women with ovarian endometriosis are not different from those in infertile women without it. This paper is centrally about endometriosis — it specifically measures blood anti-Müllerian hormone levels in infertile women with ovarian endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective – to find the level of anti-Mullerian hormone in patients with infertility and endometriosis.Material and methods. The object of the study were 55 patients with infertility and endometriosis (main group) and 30 patients with infertility without endometriosis (control group). The study included an immunofluorescent diagnostics of the anti-Muller hormone (AMH) level in the blood.Results. When performing the statistical processing of data of the main and control groups concerning the indices of AMH level, we determined that its levels in the serum of patients of the main and control groups did not differ significantly (3.5 ng / ml and 3.3 ng / ml). A clear difference in AMH blood levels was diagnosed in patients of the main group with endometriosis (3.2 ng / ml) compared with patients in whom only endometrioid heterotopies were diagnosed (7.5 ng / ml). The level of AMH in the blood of patients in the main group with primary infertility was 3.67 ng / ml, and in patients with secondary infertility 2.6 ng / ml.Conclusions. The levels of AMH in the blood serum of patients with infertility and endometriosis did not differ from its level in the blood of women with infertility but without endometriosis.
Full text 3,912 characters · extracted from oa-doi-fallback · click to expand
РІВЕНЬ АНТИМЮЛЛЕРОВОГО ГОРМОНУ В КРОВІ У ЖІНОК ІЗ БЕЗПЛІДДЯМ ПРИ ЕНДОМЕТРІОЗІ ЯЄЧНИКІВ DOI: https://doi.org/10.24061/1727-4338.XVII.4.66.2018.4Ключові слова: безпліддя та ендометріоз яєчників, антимюллеровий гормонАнотація Мета роботи – вивчити рівень антимюллерового гормону крові в пацієнток із безпліддям при ендометріозі яєчників. Матеріали та методи. Об'єктом дослідження стали 55 пацієнток із безпліддям при наявному ендометріозі яєчників (основна група) та 30 пацієнток із безпліддям за умови відсутності ендометріозу яєчників (контрольна група). Обстеження містило проведення імунофлюоресцентного дослідження рівня антимюллерового гормону в крові. Результати. Виконуючи статистичну обробку даних основної та контрольних групп стосовно показників АМГ нами виявлено, що середні рівні його в сироватці крові в пацієнток основної та контрольної груп суттєво не відрізнялися (3,5 нг/мл та 3,3 нг/мл). Рівень концентрації АМГ в крові в пацієнток основної групи дослідження при первинному безплідді становив 3,67 нг/мл, а при та вторинному безплідді – 2,6 нг/мл. Висновки. Рівень АМГ в крові в пацієнток із безпліддям та ендометріозом яєчників не відрізнявся від рівня його в крові в пацієнток із безпліддям без ендометріозу. Посилання Hoida NH, Lysenko HI, Matiukha LF, Shekera OH, Tkachenko VI. Aktual'ni problemy simeinoi medytsyny v Ukraini (za rezul'tatamy konferentsii 24–25 zhovtnia 2013 r.) [Actual problems of family medicine in Ukraine (according to the results of the conference, October 24-25, 2013)]. Family medicine. 2013;5:6-7. (in Ukrainian). Gelbaya TA, Nardo LG, Evidence-based management of endometrioma. Reprod Biomed Online. 2011;23(1):15-24. doi: 10.1016/j.rbmo.2010.11.013 Leyland N, Casper R, Laberge P, Singh SS, Allen L, Arendas K, et al. Endometriosis: diagnosis and management. J Obstet Gynaecol Can [Internet]. 2010[cited 2018 Sep 30];32(7 Suppl 2):S1-S28. Available from: https://www.sciencedirect.com/science/article/pii/S1701216316345893?via%3Dihub doi: https://doi.org/10.1016/S1701-2163(16)34589-3 Rogers PA, D'Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009;16(4):335-46. doi: 10.1177/1933719108330568 Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3);496-501. doi: 10.1093/humrep/den398 Streuli I, de Ziegler D, Gayet V, Santulli P, Bijaoui G, de Mouzon J, et al. In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery. Human Reproduction. 2012;27(11):3294-303. doi: 10.1093/humrep/des274 Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil Steril. 2008;90(3):737-43. doi: 10.1016/j.fertnstert.2007.07.1293 Raffi F, Shaw RW, Amer S. National survey of the current management of endometriomas in women undergoing assisted reproductive treatment. Human Reproduction. 2012;27(9):2712-9. doi: 10.1093/humrep/des195 Hirokawa W, Iwase A, Goto M, Takikawa S, Nagatomo Y, Nakahara T, Bayasula B, et al. The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Human Reproduction. 2011;26(4):904-10. doi: 10.1093/humrep/der006 Somigliana E, Berlanda N, Benaglia L, Vigano P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications. Fertil Steril. 2012;98:1531-8. doi: 10.1016/j.fertnstert.2012.08.009 ##submission.downloads## Опубліковано Номер Розділ Ліцензія Авторське право (c) 2019 A. V. Andriiets, O. M. Yuzko Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK